Xijiao Dihuang Decoction () and Rehmannia glutinosa Libosch. protect mice against lipopolysaccharide and tumor necrosis factor alpha-induced acute liver failure.
10.1007/s11655-015-2141-2
- Author:
Yan-Min LIU
1
;
Liu-Luan ZHU
2
;
Rui LI
2
;
Jin-Liang ZHANG
1
;
Shan-Shan YAO
1
;
Xiao-Bing ZHOU
1
;
Hui ZENG
3
;
Xian-Bo WANG
4
Author Information
1. Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
2. Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
3. Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China. zenghui@ccmu.edu.cn.
4. Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China. wangxb@ccmu.edu.cn.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
Rehmannia glutinosa Libosch.;
Xijiao Dihuang Decoction;
acute liver failure;
lipopolysaccharides;
tumor necrosis factor alpha
- From:
Chinese journal of integrative medicine
2019;25(6):446-453
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To investigate the hepatoprotective effect of Xijiao Dihuang Decoction (, XJDHD) on lipopolysaccharide (LPS)- and tumor necrosis factor alpha (TNF-α)-induced acute liver failure (ALF) as well as the underlying mechanism of action, and to clarify the key herbs and components of XJDHD.
METHODS:LPS/D-galactosamine (D-GalN) or TNF-α/D-GalN were intraperitoneally injected into C57BL/6J mice to induce ALF. Simultaneously, XJDHD or its individual herbs and components were orally administered. Survival rates, transaminase levels in serum, and hepatic histology were examined to evaluate the effects of XJDHD. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and real-time polymerase chain reaction were additionally performed to expound the mechanism underlying the anti-apoptotic activity of XJDHD.
RESULTS:Oral administration of XJDHD protected mice from lethal liver failure induced by LPS and TNF-α, with notable amelioration of liver injury in histology and a significant decrease in transaminase levels in serum. XJDHD significantly inhibited apoptosis of hepatocytes and enhanced expression of the antiapoptosis genes, c-Flip, Iap1, Gadd45b and A20. In addition, Rehmannia glutinosa Libosch. was identified as the key herb of XJDHD and galactose as the effective component of Rehmannia glutinosa Libosch. that protects against ALF.
CONCLUSIONS:XJDHD inhibits TNF-α-induced apoptosis of hepatocytes by promoting the expression of nuclear factor κ B-regulated anti-apoptotic genes. Rehmannia glutinosa Libosch. is the effective herb of XJDHD and galactose is an active component in this protection.
